Search

Search results

410 results found

The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis.

Kimball, Alexa Boer, Andrew P Yu, James Signorovitch, Jipan Xie, Magda Tsaneva, Shiraz R Gupta, Yanjun Bao, and Parvez M Mulani. 2012. “The Effects of Adalimumab Treatment and Psoriasis Severity on Self-Reported Work Productivity and Activity Impairment for Patients With Moderate to Severe Psoriasis.”. Journal of the American Academy of Dermatology 66 (2): e67-76.

Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.

Shlyankevich, Julia, Nehal N Mehta, James G Krueger, Bruce Strober, Johann E Gudjonsson, Abrar A Qureshi, Paul W Tebbey, and Alexandra Boer Kimball. 2014. “Accumulating Evidence for the Association and Shared Pathogenic Mechanisms Between Psoriasis and Cardiovascular-Related Comorbidities.”. The American Journal of Medicine 127 (12): 1148-53.

Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity.

Martin, Mona L, Kelly P McCarrier, Chiun-Fang Chiou, Kenneth Gordon, Alexa B Kimball, Abby S Van Voorhees, Alice B Gottlieb, et al. 2013. “Early Development and Qualitative Evidence of Content Validity for the Psoriasis Symptom Inventory (PSI), a Patient-Reported Outcome Measure of Psoriasis Symptom Severity.”. The Journal of Dermatological Treatment 24 (4): 255-60.